Close Menu
December 10, 2020
Sponsored by
Tecan

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

GenomeWebinar

Director, Analytical Biochemistry Applications Development, Inscripta

Senior Scientist, Applications Development, Inscripta

Head of Applications Enablement, Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. However, first-generation CRISPR technologies have been limited in scalability, accessibility, edit variety, and ease of use, restricting the potential of the technology.

Inscripta’s Onyx platform addresses these limitations by combining easy-to-use software with an automated benchtop device, enabling high efficiency, massively parallel, precision-engineered edits to Saccharomyces cerevisiae and Escherichia coli genomes. The platform offers an end-to-end solution from design through engineered strain library and analytics, accelerating the Design, Generate, Test and Learn cycle.

This webinar will present two applications in E. coli that leverage this platform technology. One application uses forward engineering with libraries totaling more than 200,000 different designs to increase lysine production by 14,000-fold. The second application is a targeted library approach with more than 900 edits, delivering new biochemical and structural insights underpinning resistance to otherwise growth-inhibitory compounds.

These applications demonstrate the power of genome-wide editing for rapid strain development.

Sponsored by

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.

Dec
02
Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion. 

Dec
10
Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Dec
10
Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms.